The non-cystic fibrosis bronchiectasis (NCFB) market size is anticipated to increase during the forecast period (2023–2032) owing to the increasing awareness and increasing diagnosed prevalent population. Moreover, the expected launch of emerging therapies by leading companies, including…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.